130 related articles for article (PubMed ID: 3890914)
21. Human immunoglobulins for intravenous use: comparison of available preparations for group B streptococcal antibody levels, opsonic activity, and efficacy in animal models.
Givner LB
Pediatrics; 1990 Dec; 86(6):955-62. PubMed ID: 2123536
[TBL] [Abstract][Full Text] [Related]
22. [Chemiluminescence of whole blood--analysis of the kinetics and application of clinical examination of phagocytic functions of whole blood from various type of diseases].
Ueno N
Hokkaido Igaku Zasshi; 1986 Nov; 61(6):947-60. PubMed ID: 3557274
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
Rainard P; Sarradin P; Poutrel B
Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
[TBL] [Abstract][Full Text] [Related]
24. Antibodies against Streptococcus agalactiae proteins c(alpha) and R4 in sera from pregnant women from Norway and Zimbabwe.
Moyo SR; Maeland JA; Mudzori J
Clin Diagn Lab Immunol; 2001 Nov; 8(6):1110-4. PubMed ID: 11687448
[TBL] [Abstract][Full Text] [Related]
25. Differences in innate immunologic response to group B streptococcus between colonized and noncolonized women.
Smith JM; Respess RH; Chaffin DG; Larsen B; Jackman SH
Infect Dis Obstet Gynecol; 2001; 9(3):125-32. PubMed ID: 11516060
[TBL] [Abstract][Full Text] [Related]
26. Response to type III polysaccharide in women whose infants have had invasive group B streptococcal infection.
Baker CJ; Rench MA; Kasper DL
N Engl J Med; 1990 Jun; 322(26):1857-60. PubMed ID: 2190087
[No Abstract] [Full Text] [Related]
27. Level of maternal antibody required to protect neonates against early-onset disease caused by group B Streptococcus type Ia: a multicenter, seroepidemiology study.
Lin FY; Philips JB; Azimi PH; Weisman LE; Clark P; Rhoads GG; Regan J; Concepcion NF; Frasch CE; Troendle J; Brenner RA; Gray BM; Bhushan R; Fitzgerald G; Moyer P; Clemens JD
J Infect Dis; 2001 Oct; 184(8):1022-8. PubMed ID: 11574917
[TBL] [Abstract][Full Text] [Related]
28. The natural history of group B streptococcal colonization in the pregnant woman and her offspring. II. Determination of serum antibody to capsular polysaccharide from type III, group B Streptococcus.
Baker CJ; Webb BJ; Kasper DL; Yow MD; Beachler CW
Am J Obstet Gynecol; 1980 May; 137(1):39-42. PubMed ID: 6989248
[TBL] [Abstract][Full Text] [Related]
29. Preventive procedures against GBS infection by means of antibody measurement.
Mikamo H; Higa M; Sato Y; Hayasaki Y; Hua YX; Yasuda-Kawazoe K; Tamaya T
Rinsho Biseibutshu Jinsoku Shindan Kenkyukai Shi; 2000 Aug; 11(1):33-7. PubMed ID: 11004709
[TBL] [Abstract][Full Text] [Related]
30. Opsonisation of group B streptococci and restriction endonuclease digestion patterns of their chromosomal DNA.
Takahashi S; Nagano Y; Nagano N; Fujita K; Taguchi F; Okuwaki Y
J Med Microbiol; 1993 Mar; 38(3):191-6. PubMed ID: 8455188
[TBL] [Abstract][Full Text] [Related]
31. BibA: a novel immunogenic bacterial adhesin contributing to group B Streptococcus survival in human blood.
Santi I; Scarselli M; Mariani M; Pezzicoli A; Masignani V; Taddei A; Grandi G; Telford JL; Soriani M
Mol Microbiol; 2007 Feb; 63(3):754-67. PubMed ID: 17212592
[TBL] [Abstract][Full Text] [Related]
32. Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates.
Källman J; Schollin J; Schalèn C; Erlandsson A; Kihlström E
Arch Dis Child Fetal Neonatal Ed; 1998 Jan; 78(1):F46-50. PubMed ID: 9536841
[TBL] [Abstract][Full Text] [Related]
33. Strain specificity of opsonins for group B streptococci types II and III.
Shigeoka AO; Hall RT; Hill HR
Infect Immun; 1979 Feb; 23(2):438-45. PubMed ID: 370017
[TBL] [Abstract][Full Text] [Related]
34. The relation of the Ibc protein antigen to the opsonization differences between strains of type II group B streptococci.
Payne NR; Ferrieri P
J Infect Dis; 1985 Apr; 151(4):672-81. PubMed ID: 3882857
[TBL] [Abstract][Full Text] [Related]
35. The role of complement in opsonization of GBS.
Edwards MS; Kasper DL; Nicholson-Weller A; Baker CJ
Antibiot Chemother (1971); 1985; 35():170-89. PubMed ID: 3901894
[No Abstract] [Full Text] [Related]
36. Blood-transfusion in group-B streptococcal sepsis.
Shigeoka AO; Hall RT; Hill HR
Lancet; 1978 Mar; 1(8065):636-8. PubMed ID: 76171
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Streptococcus pneumoniae type XIV opsonins by phagocytosis-associated chemiluminescence and a bactericidal assay.
Gardner SE; Anderson DC; Webb BJ; Stitzel AE; Edwards MS; Spitzer RE; Baker CJ
Infect Immun; 1982 Mar; 35(3):800-8. PubMed ID: 6802760
[TBL] [Abstract][Full Text] [Related]
38. [Type-specific antibody to type Ia, Ib, II and III group B Streptococcus in maternal and neonatal sera measured by ELISA].
Sugiyama M; Kojima M; Hori Y; Simizu S; Sugiyama A; Ooe Y; Nishiyama Y
Kansenshogaku Zasshi; 1990 Sep; 64(9):1232-8. PubMed ID: 2243195
[TBL] [Abstract][Full Text] [Related]
39. Methods of assessment and importance of opsonic activity for GBS.
Hill HR; Shigeoka AO; Rote NS; Allred CD; Hemming VG
Antibiot Chemother (1971); 1985; 35():157-69. PubMed ID: 3901892
[No Abstract] [Full Text] [Related]
40. Cellular and humoral aspects of host defense mechanisms against GBS.
Gotoff SP; Boyer KM
Antibiot Chemother (1971); 1985; 35():142-56. PubMed ID: 3901891
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
